WW
TMCI icon

Winnow Wealth’s Treace Medical Concepts TMCI Stock Holding History

Winnow Wealth’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.9K Sell
28,313
-1
-0% -$2 0.03% 123
2025
Q4 		$84.9K Buy
+28,314
New +$123K 0.06% 131

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winnow Wealth's TMCI Position: Q1 2026 in Review

Winnow Wealth reduced its Treace Medical Concepts (TMCI) stake by 0% in Q1 2026, selling an estimated $2 and leaving 28,313 shares worth $37.9K. The position accounts for 0.03% of the portfolio, ranked #123.

Winnow Wealth first reported a position in TMCI in Q4 2025 and has held it in 2 quarters since. The position peaked at $84.9K in Q4 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Winnow Wealth held 28,313 shares of Treace Medical Concepts worth $37.9K as of Q1 2026.
  • Winnow Wealth sold 1 Treace Medical Concepts share in Q1 2026, an estimated $2.
  • Treace Medical Concepts made up 0.03% of Winnow Wealth's portfolio in Q1 2026, its #123 holding.
  • Winnow Wealth first reported a position in Treace Medical Concepts in Q4 2025 and has held it in 2 quarters since.
  • Winnow Wealth's Treace Medical Concepts position peaked at $84.9K in Q4 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Winnow Wealth's 13F filing for Q1 2026, filed 19 May 2026.